92 related articles for article (PubMed ID: 16729120)
21. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
22. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
[TBL] [Abstract][Full Text] [Related]
23. Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR.
Nakashima KI; Yamaguchi E; Noritake C; Mitsugi Y; Goto M; Hirai T; Abe N; Sakai E; Oyama M; Itoh A; Inoue M
ACS Chem Biol; 2020 Jun; 15(6):1526-1534. PubMed ID: 32374156
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA
Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650
[TBL] [Abstract][Full Text] [Related]
26. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
Wagner CE; Jurutka PW
Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
[TBL] [Abstract][Full Text] [Related]
27. Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids.
Zapata-Gonzalez F; Rueda F; Petriz J; Domingo P; Villarroya F; Diaz-Delfin J; de Madariaga MA; Domingo JC
J Leukoc Biol; 2008 Oct; 84(4):1172-82. PubMed ID: 18632990
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
Larsen PJ; Lykkegaard K; Larsen LK; Fleckner J; Sauerberg P; Wassermann K; Wulff EM
Eur J Pharmacol; 2008 Oct; 596(1-3):173-9. PubMed ID: 18761337
[TBL] [Abstract][Full Text] [Related]
29. Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor gamma.
Gani OA; Sylte I
Chem Biol Drug Des; 2008 Jul; 72(1):50-7. PubMed ID: 18554251
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists.
Chittiboyina AG; Venkatraman MS; Mizuno CS; Desai PV; Patny A; Benson SC; Ho CI; Kurtz TW; Pershadsingh HA; Avery MA
J Med Chem; 2006 Jul; 49(14):4072-84. PubMed ID: 16821769
[TBL] [Abstract][Full Text] [Related]
31. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
Nahoum V; Pérez E; Germain P; Rodríguez-Barrios F; Manzo F; Kammerer S; Lemaire G; Hirsch O; Royer CA; Gronemeyer H; de Lera AR; Bourguet W
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17323-8. PubMed ID: 17947383
[TBL] [Abstract][Full Text] [Related]
32. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
33. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
[TBL] [Abstract][Full Text] [Related]
34. Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers.
Watanabe M; Fujihara M; Motoyama T; Kawasaki M; Yamada S; Takamura Y; Ito S; Makishima M; Nakano S; Kakuta H
J Med Chem; 2021 Jan; 64(1):430-439. PubMed ID: 33356247
[TBL] [Abstract][Full Text] [Related]
35. Interactions of methyl farnesoate and related compounds with a crustacean retinoid X receptor.
Wang YH; LeBlanc GA
Mol Cell Endocrinol; 2009 Oct; 309(1-2):109-16. PubMed ID: 19486925
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.
Zhang CH; Wen ZQ; Li JF; Li CZ; Shi M; Yang GW; Lan SM; Zhu Y; Wang F; Zhang YJ; Wang YY; Zhang H
Chin Med J (Engl); 2008 Jan; 121(2):166-71. PubMed ID: 18272045
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
da Costa Leite LF; Veras Mourão RH; de Lima Mdo C; Galdino SL; Hernandes MZ; de Assis Rocha Neves F; Vidal S; Barbe J; da Rocha Pitta I
Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
[TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
[TBL] [Abstract][Full Text] [Related]
39. A phase I study of bexarotene and rosiglitazone in patients with refractory cancers.
Read WL; Baggstrom MQ; Fracasso PM; Govindan R
Chemotherapy; 2008; 54(3):236-41. PubMed ID: 18560232
[TBL] [Abstract][Full Text] [Related]
40. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases.
van Neerven S; Kampmann E; Mey J
Prog Neurobiol; 2008 Aug; 85(4):433-51. PubMed ID: 18554773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
